glp 1 south korea Lilly's diabetes drug Mounjaro receives expanded approval for weight management in < Pharma < Article Eli Lilly establishes Mounjaro production
Description
The abdomen has slightly faster absorption in clinical data, but the difference is not clinically significant for most patients
Mechanism of action: GLP-1 receptor agonists work through multiple physiological pathways
17 Rosenstock, J., et al., Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial
The basket design reflects the recognition that obesity does not exist in isolation: its comorbidities are the clinical problem, and a drug that can address body weight, liver fat, glycaemic control, and joint load simultaneously changes the calculus
But certain groups benefit more than others
The goal is to lose fat, preserve muscle, and improve long-term movement, living, and functioning
